9 Analysts Assess Colgate-Palmolive: What You Need To Know


In the last three months, 9 analysts have published ratings on Colgate-Palmolive CL, offering a diverse range of perspectives from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 4 2 0 0
Last 30D 1 0 0 0 0
1M Ago 0 1 0 0 0
2M Ago 1 0 0 0 0
3M Ago 1 3 2 0 0

The 12-month price targets, analyzed by analysts, offer insights with an average target of $91.33, a high estimate of $96.00, and a low estimate of $82.00. This upward trend is apparent, with the current average reflecting a 6.56% increase from the previous average price target of $85.71.

Interpreting Analyst Ratings: A Closer Look

The standing of Colgate-Palmolive among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Mark Astrachan Stifel Raises Buy $94.00 $89.00
Robert Ottenstein Evercore ISI Group Raises Outperform $96.00 $90.00
Jason English Goldman Sachs Announces Buy $93.00 -
Dara Mohsenian Morgan Stanley Raises Overweight $93.00 $85.00
Peter Grom UBS Raises Buy $95.00 $93.00
Chris Carey Wells Fargo Raises Equal-Weight $88.00 $80.00
Olivia Tong Raymond James Announces Outperform $91.00 -
Andrea Teixeira JP Morgan Raises Overweight $90.00 $88.00
Lauren Lieberman Barclays Raises Equal-Weight $82.00 $75.00

Key Insights:

  • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Colgate-Palmolive. This insight gives a snapshot of analysts' perspectives on the current state of the company.
  • Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Colgate-Palmolive compared to the broader market.
  • Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Colgate-Palmolive's stock. This examination reveals shifts in analysts' expectations over time.

Capture valuable insights into Colgate-Palmolive's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Colgate-Palmolive analyst ratings.

Get to Know Colgate-Palmolive Better

Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oralcare line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International accounts for about 70% of its total sales base, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.

Colgate-Palmolive's Economic Impact: An Analysis

Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.

Revenue Growth: Colgate-Palmolive's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 6.93%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.

Net Margin: Colgate-Palmolive's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.51%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Colgate-Palmolive's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 239.33%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.43%, the company showcases effective utilization of assets.

Debt Management: With a high debt-to-equity ratio of 14.88, Colgate-Palmolive faces challenges in effectively managing its debt levels, indicating potential financial strain.

What Are Analyst Ratings?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!